New Delhi: Union Health Minister Harsh Vardhan said that late-stage clinical trials of intranasal COVID-19 vaccines are expected to be pursued by Serum Institute of India and Bharat Biotech once they receive regulatory approval.
The minister also said the late-stage trial usually involves 30,000 to 40,000 participants. Currently, the vaccines currently in Phase 3 trials are administered by injection, as per the World Health Organization (WHO).
According to India’s Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Saturday, they have received renewed approval for performing late-stage clinical trials in India of the Russian COVID-19 vaccine.
In the past 24 hours, India’s coronavirus infections surged by another 61,871, data released on Sunday showed.
Bhubaneswar: Former Indian hockey captain Prabodh Tirkey, who had resigned from Congress recently joined BJP…
Puri: Ace shuttler Saina Nehwal on Thursday visited Jagannath Temple Puri along with her mother…
Bhubaneswar: The Odisha BJP on Thursday questioned the Z-scale security cover for BJD leader and…
Bhubaneswar: A large number of leaders from Sambalpur joined Biju Janata Dal (BJD) after resigning…
Bhubaneswar: Even as Odisha continues to reel under heatwave and severe heatwave conditions, the India…
Bhubaneswar: Biju Janata Dal (BJD) on Thursday moved Odisha's Chief Electoral Officer (CEO) accusing Bharatiya…
New Delhi: Congress leader Rahul Gandhi may contest the Lok Sabha elections from Amethi after…
Bhubaneswar: Odisha can expect no respite from the searing heat anytime soon with the India…